Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Operating Income (2016 - 2025)

Historic Operating Income for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $557.1 million.

  • Fresenius Medical Care AG's Operating Income rose 962.7% to $557.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 176.78%. This contributed to the annual value of $1.5 billion for FY2024, which is 98.6% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Operating Income of $557.1 million as of Q3 2025, which was up 962.7% from $481.4 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Operating Income registered a high of $2.1 billion during Q4 2021, and its lowest value of $267.2 million during Q1 2024.
  • Moreover, its 5-year median value for Operating Income was $460.5 million (2023), whereas its average is $576.2 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Operating Income tumbled by 7014.31% in 2023, and later skyrocketed by 4396.93% in 2024.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Operating Income stood at $2.1 billion in 2021, then dropped by 27.21% to $1.5 billion in 2022, then tumbled by 70.14% to $460.5 million in 2023, then tumbled by 39.9% to $276.8 million in 2024, then surged by 101.27% to $557.1 million in 2025.
  • Its Operating Income was $557.1 million in Q3 2025, compared to $481.4 million in Q2 2025 and $348.2 million in Q1 2025.